Abstract
Although the pathogenesis of migraine is very complex and has not been thoughtfully elucidated, general consensus exists to date that this condition should be considered a primary neurovascular disorder with an important inflammatory component. Owing to epidemiological evidence of increased risk of migraine in overweight and obese subjects and to the inverse relationship that exists between serum adiponectin concentration and obesity, we performed an electronic search on Medline, Scopus and Web of Science, using the keywords “migraine” and “adiponectin” with no language or date restriction to explore the existence of an association between serum adiponectin and migraine. According to our search criteria, five studies were finally included in this systematic review, four cross-sectional (totaling 300 patients with migraine and 177 controls) and one interventional. Collectively, the results of our analysis suggest that a link between serum adiponectin and migraine remains elusive, at the best. The four cross-sectional studies failed to find any significant association, whereas the outcome of the single interventional study reported a rather modest variation of serum adiponectin concentration in a very limited sample size. Further larger studies are needed to firmly establish the existence of a relationship between adiponectin metabolism and migraine.
Similar content being viewed by others
References
Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629–808
Steiner TJ, Stovner LJ, Birbeck GL (2013) Migraine: the seventh disabler. Headache 53:227–229
Leonardi M, Raggi A (2013) Burden of migraine: international perspectives. Neurol Sci 34(Suppl 1):S117–S118
Eising E, Datson N, van den Maagdenberg AM, Ferrari MD (2013) Epigenetic mechanisms in migraine: a promising avenue? BMC Med 11:26
Chai NC, Scher AI, Moghekar A, Bond DS, Peterlin BL (2014) Obesity and headache: part I––a systematic review of the epidemiology of obesity and headache. Headache 54:219–234
Casucci G, Villani V, Cologno D, D’Onofrio F (2012) Migraine and metabolism. Neurol Sci 33(Suppl 1):S81–S85
Mather KJ, Goldberg RB (2014) Clinical use of adiponectin as a marker of metabolic dysregulation. Best Pract Res Clin Endocrinol Metab 28:107–117
Oh DK, Ciaraldi T, Henry RR (2007) Adiponectin in health and disease. Diabetes Obes Metab 9:282–289
Targher G, Bertolini L, Rodella S, Zoppini G, Scala L, Zenari L, Falezza G (2006) Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 64:679–683
Song J, Lee JE (2013) Adiponectin as a new paradigm for approaching Alzheimer’s disease. Anat Cell Biol 46:229–234
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
Peterlin BL, Alexander G, Tabby D, Reichenberger E (2008) Oligomerization state-dependent elevations of adiponectin in chronic daily headache. Neurology 70:1905–1911
Tietjen GE, Khubchandani J, Khan MA, Herial N (2010) Adiponectin and inflammatory cytokines in young women with migraine. Headache 50:71
Bernecker C, Pailer S, Kieslinger P et al (2011) Increased matrix metalloproteinase activity is associated with migraine and migraine-related metabolic dysfunctions. Eur J Neurol 18:571–576
Tietjen GE, Khubchandani J, Herial NA, Shah K (2012) Adverse childhood experiences are associated with migraine and vascular biomarkers. Headache 52:920–929
Peterlin BL, Tietjen GE, Gower BA et al (2013) Ictal adiponectin levels in episodic migraineurs: a randomized pilot trial. Headache 53:474–490
Peterlin BL (2009) The role of the adipocytokines adiponectin and leptin in migraine. J Am Osteopath Assoc 109:314–317
Neumeier M, Weigert J, Buettner R et al (2007) Detection of adiponectin in cerebrospinal fluid in humans. Am J Physiol Endocrinol Metab 293:E965–E969
Ebinuma H, Miida T, Yamauchi T et al (2007) Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid. Clin Chem 53:1541–1544
Spranger J, Verma S, Göhring I et al (2006) Adiponectin does not cross the blood–brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 55:141–147
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lippi, G., Meschi, T., Mattiuzzi, C. et al. Adiponectin and migraine: systematic review of clinical evidence. Neurol Sci 35, 1167–1171 (2014). https://doi.org/10.1007/s10072-014-1719-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-014-1719-3